Medrogestone produced in accordance with the process of this invention exhibits an HPLC strength in the order of 99.2% with total impurities at {HEAD ~ about 0.08%} , thereby providing {TAIL ~ a very pure therapeutic agent} 
providing
Medrogestone produced in accordance with the process of this invention exhibits an HPLC strength in the order of 99.2 % with total impurities at { HEAD ~ about 0.08 % } , thereby providing { TAIL ~ a very pure therapeutic agent }
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL